These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6072313)

  • 1. Human growth hormone levels in normal subjects receiving an oral contraceptive.
    Spellacy WN; Carlson KL; Schade SL
    JAMA; 1967 Nov; 202(6):451-4. PubMed ID: 6072313
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of an ovulatory suppressant on glucose tolernce and insulin secretion.
    Pi-Sunyer FX; Oster S
    Obstet Gynecol; 1968 Apr; 31(4):482-4. PubMed ID: 5643126
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucose and insulin alterations after one year of combination-type oral contraceptive treatment.
    Spellacy WN; Carlson KL; Birk SA; Schade SL
    Metabolism; 1968 Jun; 17(6):496-501. PubMed ID: 4870715
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of growth hormone in the alteration of carbohydrate metabolism induced by oral contraceptive agents.
    Davidson MB; Holzman GB
    J Clin Endocrinol Metab; 1973 Feb; 36(2):246-55. PubMed ID: 4683182
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral contraceptives and follicle-stimulating hormone.
    Cargille CM; Ross GT
    Lancet; 1968 Apr; 1(7548):924. PubMed ID: 4171528
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum luteinizing and follicle stimulating hormone levels during sequential and nonsequential contraceptive treatment of eugonadal women.
    Swerdloff RS; Odell WD
    J Clin Endocrinol Metab; 1969 Feb; 29(2):157-63. PubMed ID: 4179302
    [No Abstract]   [Full Text] [Related]  

  • 7. Some effects of oral contraceptives on carbohydrate metabolism.
    Wynn V; Doar JW
    Lancet; 1966 Oct; 2(7466):715-9. PubMed ID: 4162055
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin and glucose determinations after two and three years of use of a combination-type oral contraceptive.
    Spellacy WN; Bendel RP; Buhi WC; Birk SA
    Fertil Steril; 1969; 20(6):892-902. PubMed ID: 5361464
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of growth and width of tibial cartilage in rats by a contraceptive agent.
    Husain SM; Brazeau P; Saucier R
    Growth; 1969 Mar; 33(1):17-24. PubMed ID: 5790343
    [No Abstract]   [Full Text] [Related]  

  • 10. Postmedication fertility in female rats treated with a norethynodrel-mestranol combination (Enovid).
    Husain SM; Pincus G
    Rev Can Biol; 1968 Sep; 27(3):137-40. PubMed ID: 5702436
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of the contraceptive steroids norethynodrel and mestranol on dental caries activity in young adult female rats.
    Liu FT; Lin HS
    J Dent Res; 1973; 52(4):753-7. PubMed ID: 4515857
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of oral administration of a norethynodrel-mestranol combination (Enovid) in rats.
    Husain SM; Pincus G
    Rev Can Biol; 1968 Sep; 27(3):217-24. PubMed ID: 5702438
    [No Abstract]   [Full Text] [Related]  

  • 13. Long term effects of administering an oral contraceptive on some liver enzymes of rats & mice.
    Padbidri JR; Joshi UM; Rao SS
    Indian J Exp Biol; 1966 Oct; 4(4):219-21. PubMed ID: 5977556
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical evaluation of long-term continuous use of norethynodrel-mestranol for contraception.
    Tyler ET; Cole SL; Levin M; Elliot J
    Fertil Steril; 1969; 20(6):871-83. PubMed ID: 5361462
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of ethynodiol diacetate and mestranol on blood glucose and plasma insulin. I. Six month oral glucose tolerance test.
    Spellacy WN; Buhi WC; Birk SA; McCreary SA
    Int J Fertil; 1971; 16(2):55-65. PubMed ID: 5092534
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth hormone alterations by a sequential-type oral contraceptive.
    Spellacy WN; Buhi WC; Bendel RP
    Obstet Gynecol; 1969 Apr; 33(4):506-10. PubMed ID: 4180423
    [No Abstract]   [Full Text] [Related]  

  • 17. Ovulatory suppressants, estrogens, and carbohydrate metabolism.
    Javier Z; Gershberg H; Hulse M
    Metabolism; 1968 May; 17(5):443-56. PubMed ID: 4171881
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma renin activity and aldosterone excretion rate in normal subjects. II. Effect of oral contraceptive agents.
    Crane MG; Harris JJ
    J Clin Endocrinol Metab; 1969 Apr; 29(4):558-62. PubMed ID: 5779248
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of contraceptive steroids on metabolism of glutamic acid & GABA in rat brain.
    Rao IM; Murthy CR; Reddy PR
    Indian J Med Res; 1984 Nov; 80():577-82. PubMed ID: 6152245
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum copper alteration after ingestion of an oral contraceptive.
    O'Leary JA; Spellacy WN
    Science; 1968 Nov; 162(3854):682. PubMed ID: 4879933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.